Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,083 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent advances in immunotherapy for non-small-cell lung cancer.
Suzuki H, Owada Y, Watanabe Y, Inoue T, Fukuharav M, Yamaura T, Mutoh S, Okabe N, Yaginuma H, Hasegawa T, Yonechi A, Ohsugi J, Hoshino M, Higuchi M, Shio Y, Gotoh M. Suzuki H, et al. Among authors: watanabe y. Hum Vaccin Immunother. 2014;10(2):352-7. doi: 10.4161/hv.26919. Epub 2013 Nov 6. Hum Vaccin Immunother. 2014. PMID: 24196313 Free PMC article. Review.
Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma.
Osugi J, Kimura Y, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Yonechi A, Hoshino M, Higuchi M, Shio Y, Suzuki H, Gotoh M. Osugi J, et al. Among authors: watanabe y. J Oncol. 2015;2015:316745. doi: 10.1155/2015/316745. Epub 2015 Feb 5. J Oncol. 2015. PMID: 25733977 Free PMC article.
Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons.
Higuchi M, Takagi H, Owada Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Yonechi A, Osugi J, Hoshino M, Shio Y, Fujiu K, Kanno R, Ohishi A, Suzuki H, Gotoh M. Higuchi M, et al. Among authors: watanabe y. Oncol Lett. 2017 Jun;13(6):4315-4321. doi: 10.3892/ol.2017.5998. Epub 2017 Apr 5. Oncol Lett. 2017. PMID: 28599432 Free PMC article.
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
Yamaura T, Ezaki J, Okabe N, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Fukuhara M, Muto S, Matsumura Y, Hasegawa T, Hoshino M, Osugi J, Shio Y, Waguri S, Tamura H, Imai JI, Ito E, Yanagisawa Y, Honma R, Watanabe S, Suzuki H. Yamaura T, et al. Among authors: watanabe s, watanabe y. Oncol Lett. 2018 Feb;15(2):1549-1558. doi: 10.3892/ol.2017.7517. Epub 2017 Dec 5. Oncol Lett. 2018. PMID: 29434849 Free PMC article.
Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.
Higuchi M, Takagi H, Ozaki Y, Inoue T, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Shio Y, Suzuki H. Higuchi M, et al. Among authors: watanabe y. Fukushima J Med Sci. 2018 Apr 17;64(1):30-37. doi: 10.5387/fms.2017-10. Epub 2018 Feb 20. Fukushima J Med Sci. 2018. PMID: 29459574 Free PMC article.
Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.
Owada-Ozaki Y, Muto S, Takagi H, Inoue T, Watanabe Y, Fukuhara M, Yamaura T, Okabe N, Matsumura Y, Hasegawa T, Ohsugi J, Hoshino M, Shio Y, Nanamiya H, Imai JI, Isogai T, Watanabe S, Suzuki H. Owada-Ozaki Y, et al. Among authors: watanabe s, watanabe y. J Thorac Oncol. 2018 Aug;13(8):1217-1221. doi: 10.1016/j.jtho.2018.04.003. Epub 2018 Apr 12. J Thorac Oncol. 2018. PMID: 29654927 Free article.
12,083 results
You have reached the last available page of results. Please see the User Guide for more information.